MedPath

Evaluation of effects of pomegeranate seed oil on lipid profiles, apolipoproteines and body composition in subjects with low HDL-C concentrations

Not Applicable
Conditions
low HDL-C concentrations.
Disorders of lipoprotein metabolism and other lipidaemias
Registration Number
IRCT201107201640N5
Lead Sponsor
Research Institute for Endocrine Science, Shaheed Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
150
Inclusion Criteria

willingness to cooperate; ages 20-70 years; those with 35= BMI (kg/m2) =25; having levels of HDL-C <40mgr/dl in the last 12 months; Who are placed in stage I and stage II on TLC, according to NCEP ATP III criteria; Diabetic people not used Glitazones and insulin or consume constantly oral diabetes medications for at least three months Even if taking anti-lipid medications (statins and fibers); Lack of breastfeeding and pregnancy; Those who have had less than 5 Kg in body weight in the last 3 months; Not having any thyroid disorders and kidney failure; Lack of any severe mental illness; Not having cancer in the past five years; Lack of peptic ulcer disease; No smoking and alcohol; Not using drugs affecting lipid profile such as corticosteroids, cyclosporine, propranolol and glucocorticoid. Exclusion criteria: weight loss >10Kg during the study, Diagnosis of any of the diseases mentioned in inclusion criteria, during the study; Patient's lack of cooperation in each of the stages studied.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ow HDL-C. Timepoint: baseline and end of weeks 2, 4, 8 and 12. Method of measurement: Enzymatic colorimetric method and sediment specific.
Secondary Outcome Measures
NameTimeMethod
Body weight. Timepoint: at the start and end of the 12 weeks study. Method of measurement: anthropometric measurements.;Blood pressure. Timepoint: at the start and end of the 12 weeks study. Method of measurement: blood pressure measurement.
© Copyright 2025. All Rights Reserved by MedPath